Literature DB >> 26238251

Transaldolase Deficiency: A New Case Expands the Phenotypic Spectrum.

Ehud Banne1, Vardiella Meiner2, Avraham Shaag2,3, Rachel Katz-Brull4, Ayelet Gamliel4, Stanley Korman2,3, Smadar Horowitz Cederboim2, Morasha Plesser Duvdevani2, Ayala Frumkin2,3, Amir Zilkha5, Vadim Kapuller6, Dan Arbell6, Elite Cohen7, Smadar Eventov-Friedman7.   

Abstract

Transaldolase (TALDO) deficiency has various clinical manifestations including liver dysfunction, hepatosplenomegaly, anemia, thrombocytopenia, and dysmorphic features. We report a case presenting prenatally with hyperechogenic bowel and intrauterine growth restriction. The infant was born small for gestational age, with cutis laxa and hypertrichosis. Postnatally, meconium plug was identified, complicated with intestinal obstruction necessitating laparotomy, partial resection of the intestine, and ileostomy. Liver biopsy revealed cholangiolar proliferation and portal fibrosis. He also suffered from persistent congenital thrombocytopenia requiring platelet transfusions and severe hypothyroidism with normal anatomical and structural gland responding only to the combination of T3 and T4 treatment. Neurologically, severe hypotonia and anisocoria were noted at the age of 2 months. Brain MRI was normal. Shortly after the abdominal surgery, a rapid liver failure ensued, which eventually led to his death. Specific metabolic tests ruled out glycosylation disorders, yet urine analysis using 1H NMR showed accumulation of sedoheptulose which was previously described in patients with transaldolase deficiency. Sequencing of the gene-encoding transaldolase (TALDO1) revealed a homozygous stop mutation c.669C>G; p.Tyr223*. In conclusion, we present an infant with a novel homozygous mutation in TALDO1, causing TALDO deficiency, and extend the clinical characteristics of this rare syndrome.

Entities:  

Keywords:  Cutis laxa; Echogenic bowel; Hypothyroidism; Microarray analysis; Transaldolase

Year:  2015        PMID: 26238251      PMCID: PMC4864716          DOI: 10.1007/8904_2015_474

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  21 in total

Review 1.  Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.

Authors:  Andras Perl; Robert Hanczko; Tiffany Telarico; Zachary Oaks; Steve Landas
Journal:  Trends Mol Med       Date:  2011-03-02       Impact factor: 11.951

2.  The clinical significance of fetal echogenic bowel.

Authors:  H B Al-Kouatly; S T Chasen; J Streltzoff; F A Chervenak
Journal:  Am J Obstet Gynecol       Date:  2001-11       Impact factor: 8.661

3.  Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure.

Authors:  S Balasubramaniam; Mirjam M C Wamelink; Lock-Hock Ngu; Arni Talib; Gajja S Salomons; Cornelis Jakobs; Wee-Teik Keng
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-01       Impact factor: 2.839

Review 4.  Failure to pass meconium: diagnosing neonatal intestinal obstruction.

Authors:  V Loening-Baucke; K Kimura
Journal:  Am Fam Physician       Date:  1999-11-01       Impact factor: 3.292

5.  A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency.

Authors:  N M Verhoeven; M Wallot; J H J Huck; O Dirsch; A Ballauf; U Neudorf; G S Salomons; M S van der Knaap; T Voit; C Jakobs
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

6.  Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease.

Authors:  Vassili Valayannopoulos; Nanda M Verhoeven; Karine Mention; Gajja S Salomons; Danièle Sommelet; Marie Gonzales; Guy Touati; Pascale de Lonlay; Cornelis Jakobs; Jean-Marie Saudubray
Journal:  J Pediatr       Date:  2006-11       Impact factor: 4.406

7.  Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway.

Authors:  N M Verhoeven; J H Huck; B Roos; E A Struys; G S Salomons; A C Douwes; M S van der Knaap; C Jakobs
Journal:  Am J Hum Genet       Date:  2001-03-27       Impact factor: 11.025

Review 8.  Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation.

Authors:  Hubert P J van der Doef; Freddy T M Kokke; Cornelis K van der Ent; Roderick H J Houwen
Journal:  Curr Gastroenterol Rep       Date:  2011-06

Review 9.  Metabolic cutis laxa syndromes.

Authors:  Miski Mohamed; Dorus Kouwenberg; Thatjana Gardeitchik; Uwe Kornak; Ron A Wevers; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2011-03-23       Impact factor: 4.982

10.  Clinical and molecular characteristics of two transaldolase-deficient patients.

Authors:  Anna Tylki-Szymanska; Mirjam M C Wamelink; Teresa J Stradomska; Gajja S Salomons; Joanna Taybert; Nel Dąbrowska-Leonik; Małgorzata Rurarz
Journal:  Eur J Pediatr       Date:  2014-02-05       Impact factor: 3.183

View more
  6 in total

1.  Long-Term Systematic Monitoring of Four Polish Transaldolase Deficient Patients.

Authors:  Patryk Lipiński; Joanna Pawłowska; Teresa Stradomska; Elżbieta Ciara; Irena Jankowska; Piotr Socha; Anna Tylki-Szymańska
Journal:  JIMD Rep       Date:  2018-01-03

2.  N-Acetylcysteine Therapy in an Infant with Transaldolase Deficiency Is Well Tolerated and Associated with Normalization of Alpha Fetoprotein Levels.

Authors:  Lance H Rodan; Gerard T Berry
Journal:  JIMD Rep       Date:  2016-04-30

Review 3.  Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism.

Authors:  Mohamed Abu-Farha; Salman Al-Sabah; Maha M Hammad; Prashantha Hebbar; Arshad Mohamed Channanath; Sumi Elsa John; Ibrahim Taher; Abdulrahman Almaeen; Amany Ghazy; Anwar Mohammad; Jehad Abubaker; Hossein Arefanian; Fahd Al-Mulla; Thangavel Alphonse Thanaraj
Journal:  Front Pharmacol       Date:  2020-12-09       Impact factor: 5.810

4.  Prenatal Diagnosis of Fetus With Transaldolase Deficiency Identifies Compound Heterozygous Variants: A Case Report.

Authors:  Jiaxin Xue; Jin Han; Xiaopeng Zhao; Li Zhen; Shanshan Mei; Zhiyang Hu; Xiuzhen Li
Journal:  Front Genet       Date:  2022-02-04       Impact factor: 4.599

5.  Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics.

Authors:  Jia-You Lin; Bao-Rong Juo; Yu-Hsuan Yeh; Shu-Hsuan Fu; Yi-Ting Chen; Chien-Lun Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2021-06-05       Impact factor: 3.169

6.  Discriminating high-risk cervical Human Papilloma Virus infections with urinary biomarkers via non-targeted GC-MS-based metabolomics.

Authors:  Filipa Godoy-Vitorino; Gilmary Ortiz-Morales; Josefina Romaguera; Maria M Sanchez; Magaly Martinez-Ferrer; Natalyia Chorna
Journal:  PLoS One       Date:  2018-12-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.